Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210042634> ?p ?o ?g. }
- W3210042634 endingPage "149" @default.
- W3210042634 startingPage "143" @default.
- W3210042634 abstract "Several mechanisms have been suggested to explain positive cardiovascular effects observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction in glucose reabsorption in proximal tubuli induced by SGLT2 inhibitors increases urinary glucose and sodium excretion resulting in increased osmotic diuresis and consequently in decreased plasma volume, followed by reduced preload. In addition, the hemodynamic effects of SGLT2 inhibition were observed in both hyper and euglycemic patients. Due to the complex and multidirectional effects induced by SGLT2 inhibitors, this originally antidiabetic group of drugs has been successfully used to treat patients with heart failure as well as for subjects with chronic kidney disease. Moreover, their therapeutic potential seems to be even broader than the indications studied to date." @default.
- W3210042634 created "2021-11-08" @default.
- W3210042634 creator A5001190600 @default.
- W3210042634 creator A5005207274 @default.
- W3210042634 creator A5007198463 @default.
- W3210042634 creator A5007912506 @default.
- W3210042634 creator A5008313206 @default.
- W3210042634 creator A5010805821 @default.
- W3210042634 creator A5016342830 @default.
- W3210042634 creator A5018550267 @default.
- W3210042634 creator A5021903478 @default.
- W3210042634 creator A5022932356 @default.
- W3210042634 creator A5023968854 @default.
- W3210042634 creator A5024458724 @default.
- W3210042634 creator A5030107346 @default.
- W3210042634 creator A5041209352 @default.
- W3210042634 creator A5043527909 @default.
- W3210042634 creator A5045551258 @default.
- W3210042634 creator A5062728459 @default.
- W3210042634 creator A5067379673 @default.
- W3210042634 creator A5067935886 @default.
- W3210042634 creator A5069182559 @default.
- W3210042634 creator A5071273910 @default.
- W3210042634 creator A5076248659 @default.
- W3210042634 creator A5080419099 @default.
- W3210042634 creator A5080804609 @default.
- W3210042634 creator A5083234837 @default.
- W3210042634 date "2023-02-27" @default.
- W3210042634 modified "2023-10-14" @default.
- W3210042634 title "Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients" @default.
- W3210042634 cites W1943654307 @default.
- W3210042634 cites W1964891036 @default.
- W3210042634 cites W2050144111 @default.
- W3210042634 cites W2062351818 @default.
- W3210042634 cites W2078902399 @default.
- W3210042634 cites W2079747172 @default.
- W3210042634 cites W2133469996 @default.
- W3210042634 cites W2142065502 @default.
- W3210042634 cites W2146264128 @default.
- W3210042634 cites W2153819921 @default.
- W3210042634 cites W2157405334 @default.
- W3210042634 cites W2237317573 @default.
- W3210042634 cites W2271287115 @default.
- W3210042634 cites W2344983246 @default.
- W3210042634 cites W2425017047 @default.
- W3210042634 cites W2538443876 @default.
- W3210042634 cites W2613261853 @default.
- W3210042634 cites W2626446274 @default.
- W3210042634 cites W2763866789 @default.
- W3210042634 cites W2766617433 @default.
- W3210042634 cites W2772204795 @default.
- W3210042634 cites W2772844083 @default.
- W3210042634 cites W2785119187 @default.
- W3210042634 cites W2793304287 @default.
- W3210042634 cites W2886261460 @default.
- W3210042634 cites W2890539106 @default.
- W3210042634 cites W2892498615 @default.
- W3210042634 cites W2894852767 @default.
- W3210042634 cites W2913223653 @default.
- W3210042634 cites W2920243595 @default.
- W3210042634 cites W2948866758 @default.
- W3210042634 cites W2953132927 @default.
- W3210042634 cites W2965056983 @default.
- W3210042634 cites W2967001872 @default.
- W3210042634 cites W2974260792 @default.
- W3210042634 cites W2984683166 @default.
- W3210042634 cites W2986400602 @default.
- W3210042634 cites W3003546904 @default.
- W3210042634 cites W3044410554 @default.
- W3210042634 cites W3044587152 @default.
- W3210042634 cites W3046673571 @default.
- W3210042634 cites W3081830235 @default.
- W3210042634 cites W3082758064 @default.
- W3210042634 cites W3084081810 @default.
- W3210042634 cites W3115836333 @default.
- W3210042634 cites W3115897008 @default.
- W3210042634 cites W3118491390 @default.
- W3210042634 doi "https://doi.org/10.5603/cj.a2021.0133" @default.
- W3210042634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34708866" @default.
- W3210042634 hasPublicationYear "2023" @default.
- W3210042634 type Work @default.
- W3210042634 sameAs 3210042634 @default.
- W3210042634 citedByCount "0" @default.
- W3210042634 crossrefType "journal-article" @default.
- W3210042634 hasAuthorship W3210042634A5001190600 @default.
- W3210042634 hasAuthorship W3210042634A5005207274 @default.
- W3210042634 hasAuthorship W3210042634A5007198463 @default.
- W3210042634 hasAuthorship W3210042634A5007912506 @default.
- W3210042634 hasAuthorship W3210042634A5008313206 @default.
- W3210042634 hasAuthorship W3210042634A5010805821 @default.
- W3210042634 hasAuthorship W3210042634A5016342830 @default.
- W3210042634 hasAuthorship W3210042634A5018550267 @default.
- W3210042634 hasAuthorship W3210042634A5021903478 @default.
- W3210042634 hasAuthorship W3210042634A5022932356 @default.
- W3210042634 hasAuthorship W3210042634A5023968854 @default.
- W3210042634 hasAuthorship W3210042634A5024458724 @default.
- W3210042634 hasAuthorship W3210042634A5030107346 @default.
- W3210042634 hasAuthorship W3210042634A5041209352 @default.